These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 573103)

  • 1. [Comparative pharmacokinetic study of two new compounds of the nitronaphthalimides series with cytostatic activity (author's transl)].
    Idoipe A; Santillán MS; Martínez-Larrañaga MR; González E; García de Jalón PD
    Arch Farmacol Toxicol; 1979 Apr; 5(1):17-22. PubMed ID: 573103
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetic and distribution studies in rats and mice of 14C-brovanexine (author's transl)].
    Rimbau V; Torralba A
    Arch Farmacol Toxicol; 1978 Aug; 4(2):253-60. PubMed ID: 727838
    [No Abstract]   [Full Text] [Related]  

  • 3. Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation.
    Harmange JC; Weiss MM; Germain J; Polverino AJ; Borg G; Bready J; Chen D; Choquette D; Coxon A; DeMelfi T; DiPietro L; Doerr N; Estrada J; Flynn J; Graceffa RF; Harriman SP; Kaufman S; La DS; Long A; Martin MW; Neervannan S; Patel VF; Potashman M; Regal K; Roveto PM; Schrag ML; Starnes C; Tasker A; Teffera Y; Wang L; White RD; Whittington DA; Zanon R
    J Med Chem; 2008 Mar; 51(6):1649-67. PubMed ID: 18324761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of experimental results in clinical tumor chemotherapy (author's transl)].
    Somfai-Relle S; Sugár J
    Arch Geschwulstforsch; 1980; 50(2):132-40. PubMed ID: 7436697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of a new antiarrhythmic drug, bunaftine, after oral administration (author's transl)].
    Flouvat B; Roux A; Decourt S; Caron A
    Therapie; 1982; 37(2):143-9. PubMed ID: 7112484
    [No Abstract]   [Full Text] [Related]  

  • 6. Bis-naphthalimides: a new class of antitumor agents.
    Braña MF; Castellano JM; Morán M; Pérez de Vega MJ; Romerdahl CR; Qian XD; Bousquet P; Emling F; Schlick E; Keilhauer G
    Anticancer Drug Des; 1993 Aug; 8(4):257-68. PubMed ID: 8240655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors.
    Weiss MM; Harmange JC; Polverino AJ; Bauer D; Berry L; Berry V; Borg G; Bready J; Chen D; Choquette D; Coxon A; DeMelfi T; Doerr N; Estrada J; Flynn J; Graceffa RF; Harriman SP; Kaufman S; La DS; Long A; Neervannan S; Patel VF; Potashman M; Regal K; Roveto PM; Schrag ML; Starnes C; Tasker A; Teffera Y; Whittington DA; Zanon R
    J Med Chem; 2008 Mar; 51(6):1668-80. PubMed ID: 18324759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of penberol (author's transl)].
    Grafnetterová J; Smahel O; Matl I; König J
    Cas Lek Cesk; 1976; 115(16):477-80. PubMed ID: 773538
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis, biological activity, and quantitative structure-activity relationship study of azanaphthalimide and arylnaphthalimide derivatives.
    Braña MF; Gradillas A; Gómez A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle F; Yuste M; Campos J; Gallo MA; Espinosa A
    J Med Chem; 2004 Apr; 47(9):2236-42. PubMed ID: 15084122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tactics of the cytostatic treatment in ovarian cancers (author's transl)].
    Budinská B
    Cesk Gynekol; 1976 Dec; 41(10):722-3. PubMed ID: 1009603
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pivampicillin: pharmacokinetic and clinical evaluation in children (author's transl)].
    Daschner F; Marget W
    Med Klin; 1974 Feb; 69(8):341-5. PubMed ID: 4826682
    [No Abstract]   [Full Text] [Related]  

  • 12. [Example of dose finding in practice. Pharmacology of an antiarrhythmic agent (author's transl)].
    Oberdorf A; Raschack M
    Arzneimittelforschung; 1977 Feb; 27(2A):281-3. PubMed ID: 577176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fate of cobalt-60 I-nitroso 2-naphthol chelate in albino rats after intravenous administration.
    Jagadeesan V; Sivaramakrishnan VM
    Indian J Exp Biol; 1969 Oct; 7(4):217-20. PubMed ID: 5359087
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinico-pharmacological studies on the pharmacokinetics of a combination sulfamethoxazol/trimethoprim in normal subjects (author's transl)].
    Donike M; Lücker PW; Simon B
    Arzneimittelforschung; 1977; 27(12):2373-7. PubMed ID: 580054
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetics and bioavailability of alizapride (author's transl)].
    Houin G; Bree F; Tillement JP
    Sem Hop; 1982 Feb; 58(6):339-44. PubMed ID: 6280299
    [No Abstract]   [Full Text] [Related]  

  • 16. [Application of a micromethod for sampling and for the specific quantitative evaluation of quinidine. I. Pharmacokinetic study after intravenous administration in the rat (author's transl)].
    Koskas JP; Sado PA; Devissaguet JP; Le Verge R
    J Pharm Belg; 1981; 36(3):187-92. PubMed ID: 7264865
    [No Abstract]   [Full Text] [Related]  

  • 17. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The preliminary farmacological investigations of the central action of new derivatives of tetrahydrophtalimides (author's transl)].
    Kleinrok Z; Przesmycki K; Borzecki Z
    Ann Univ Mariae Curie Sklodowska Med; 1973; 28():213-20. PubMed ID: 4789853
    [No Abstract]   [Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of substituted naphthalene imides and diimides as anticancer agent.
    Tumiatti V; Milelli A; Minarini A; Micco M; Gasperi Campani A; Roncuzzi L; Baiocchi D; Marinello J; Capranico G; Zini M; Stefanelli C; Melchiorre C
    J Med Chem; 2009 Dec; 52(23):7873-7. PubMed ID: 19954251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic studies on 3H-N-Hydroxycantharidinimide (author's transl)].
    Ho SX; Wu L; Lu PH
    Yao Xue Xue Bao; 1981 May; 16(5):328-33. PubMed ID: 7246178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.